Cardiac disease was once thought to be both progressive and irreversible. As stem cell therapies emerge across many fields of medicine, our patients with cardiac disorders may be among the first to benefit from this translation of basic science into very valuable clinical applications. What do the latest findings tell us about our ability to tap into the promise of stem cells to treat, reverse or even prevent cardiac disease? Dr. Joshua Hare, director of the Interdisciplinary Stem Cell Institute and the Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine, walks us through the most promising developments in this cutting-edge research and provides his insights on how you can talk with your patients about where they can expect to see benefits in the short term. Dr. Janet Wright hosts.
Forging a Path Toward Cardiac Applications for Stem Cells

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Cardiac disease was once thought to be both progressive and irreversible. As stem cell therapies emerge across many fields of medicine, our patients with cardiac disorders may be among the first to benefit from this translation of basic science into very valuable clinical applications. What do the latest findings tell us about our ability to tap into the promise of stem cells to treat, reverse or even prevent cardiac disease? Dr. Joshua Hare, director of the Interdisciplinary Stem Cell Institute and the Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine, walks us through the most promising developments in this cutting-edge research and provides his insights on how you can talk with your patients about where they can expect to see benefits in the short term. Dr. Janet Wright hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Level Up Your Skills: Tailoring Management of HF
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?